SuperworthOcular Therapeutix shares outstanding OCUL
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Jun 30, 2026
- 225M
- On a year earlier
- +30.3%
- more shares
Ocular Therapeutix had 225M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 30.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 222.5M | +32% |
| FY2024 | 168M | +99% |
| FY2023 | 84.4M | +10% |
| FY2022 | 77M | +1% |
| FY2021 | 76.6M | +8% |
| FY2020 | 70.6M | +44% |
| FY2019 | 48.9M | +19% |
| FY2018 | 41.1M | +39% |
| FY2017 | 29.5M | +18% |
| FY2016 | 24.9M | +1% |
| FY2015 | 24.7M | +16% |
| FY2014 | 21.3M | +700% |
| FY2013 | 2.7M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 225M | +30% | |
| Q1 FY26 | 224.1M | +32% | |
| Q4 FY25 | 222.5M | +32% | |
| Q3 FY25 | 183.9M | +10% | |
| Q2 FY25 | 172.6M | +4% | |
| Q1 FY25 | 169.4M | +28% | |
| Q4 FY24 | 168M | +99% | |
| Q3 FY24 | 167M | +96% | |
| Q2 FY24 | 165.8M | +112% | |
| Q1 FY24 | 132M | +71% | |
| Q4 FY23 | 84.4M | +10% | |
| Q3 FY23 | 85.1M | +11% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Ocular Therapeutix
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.